Dr. Stephan Wnendt and Dr. Katja Neuer Join Achelous Partners as European Representatives
Dr. Wnendt and Dr. Neuer will bolster Achelous' capabilities in Germany as well as throughout Europe
NEW YORK, Jan. 5, 2021 /PRNewswire-PRWeb/ -- Achelous Partners, LLC is pleased to announce that Dr. Stephan Wnendt and Dr. Katja Neuer have been appointed as European Representatives. Dr. Wnendt and Dr. Neuer are both based in Germany, which is one of Achelous Partners' fastest growing markets in Europe.
"Both Dr. Wnendt and Dr. Neuer have significant expertise in the life science sector and have developed client relationships built on over 25 years in the industry. Achelous Partners has completed a number of transactions throughout Germany over the past several years, including for our clients MLM MedicalLabs GmbH, NovaTech Immundiagnostica, LifeCodexx, and IBL International. Germany is a core growth area for Achelous Partners and we have spent many years building relationships with leading life science companies throughout the region. Dr. Wnendt and Dr. Neuer will significantly bolster our ability to assist our clients in Germany, as well as locate new opportunities globally," said Mark Saunders, President of Achelous Partners.
Dr. Wnendt and Dr. Neuer join Achelous Partners from MLM Medical Labs GmbH, where Dr. Wnendt served as CEO and Dr. Neuer served as Director of Business Development. MLM is a central laboratory dedicated exclusively to clinical trials. During their tenure, MLM grew organically into a highly profitable central lab with double digit revenue and a highly diversified global client base. Achelous Partners advised MLM on its sale to the US based life science focused private equity fund, Great Point Partners, during 2019.
"Achelous has a reputation for best-in-class M&A services throughout the global life science and healthcare sectors and they did a tremendous job completing a very successful transaction for MLM," said Dr. Wnendt. "We have developed relationships with many independent life science companies and private equity funds that could benefit from Achelous' M&A expertise, and we are excited to work with Achelous to help those companies achieve their strategic and financial goals," added Dr. Neuer.
Achelous Partners, LLC is an independent investment bank known internationally for advising on global mergers and acquisitions for life science and healthcare companies, with a focus on sell-side mandates, buy-side mandates, valuations, fairness opinions, restructurings, divestures, and strategic advisory. Based in New York, Achelous specializes in serving a substantial global client base of life science and healthcare companies.
Media Contact
Eric Zitter, Achelous Partners, LLC, +1 6462617485, [email protected]
SOURCE Achelous Partners, LLC
Share this article